Patents by Inventor Elizabeth Hauser

Elizabeth Hauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lsamp gene associated with cardiovascular disease
    Publication number: 20110070583
    Abstract: The LSAMP gene can be used for cardiovascular disease risk assessment, in particular Left Main Disease. The genetic risk attributable to LSAMP adds to known cardiovascular disease risk factors. Assessment of risk attributable to LSAMP permits early initiation of preventive and therapeutic strategies. Given the pronounced clinical risk associated with Left Main Disease, such risk assessment should significantly reduce morbidity and mortality.
    Type: Application
    Filed: August 19, 2010
    Publication date: March 24, 2011
    Inventors: Jeffery M. Vance, Pascal Goldschmidt, Elizabeth Hauser, William Kraus, Margaret A. Pericak-Vance
  • Methods of Determining the Risk of Developing Coronary Artery Disease
    Publication number: 20090226420
    Abstract: The invention relates to predicting, or aiding in predicting, which individuals are at risk of developing coronary artery disease. The invention provides a method for identifying an individual who has an altered risk for developing CAD. The invention further relates to methods of reducing the likelihood that a subject will develop CAD. The invention further provides reagents, nucleic acids and kits comprising nucleic acids containing a polymorphism in a CAD-determinative gene.
    Type: Application
    Filed: November 10, 2006
    Publication date: September 10, 2009
    Inventors: Elizabeth Hauser, Pascal Goldschmidt, Simon Gregory, William Kraus, Jeffery Vance
  • LSAMP Gene Associated With Cardiovascular Disease
    Publication number: 20070148661
    Abstract: The LSAMP gene can be used for cardiovascular disease risk assessment, in particular Left Main Disease. The genetic risk attributable to LSAMP adds to known cardiovascular disease risk factors. Assessment of risk attributable to LSAMP permits early initiation of preventive and therapeutic strategies. Given the pronounced clinical risk associated with Left Main Disease, such risk assessment should significantly reduce morbidity and mortality.
    Type: Application
    Filed: July 18, 2006
    Publication date: June 28, 2007
    Applicant: Duke University
    Inventors: Jeffery Vance, Pascal Goldschmidt, Elizabeth Hauser, William Kraus, Margaret Pericak-Vance